Drawing for VETERINARY CLINICAL PATHOLOGY

USPTO serial 75367886

VETERINARY CLINICAL PATHOLOGY

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
BLOHM, LINDA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VETERINARY CLINICAL PATHOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL D FISHMAN

MICHAEL D FISHMAN RADER FISHMAN & GRAUER PLLC1533 N WOODWARD AVE STE 140BLOOMFIELD HILLS, MI 48304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016PRINTED PUBLICATIONS, NAMELY, JOURNALS IN THE FIELD OF ANIMALS AND OTHER SPECIESABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 1999ABN1ABANDONMENT - EXPRESS MAILED—
Apr 27, 1999ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 19, 1999DOCKASSIGNED TO EXAMINER—
Feb 2, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 1998DOCKASSIGNED TO EXAMINER—
May 20, 1998DOCKASSIGNED TO EXAMINER—
May 19, 1998DOCKASSIGNED TO EXAMINER—
May 11, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance